DRKS00028976招募中不适用
German translation and validation of the „Multifaceted Peritraumatic Responses to Child Abuse Inventory (MPR-CA) of Katz C. et al. 2021
Klinik für Psychiatrie und Psychotherapie I der Universität Ulm0 个研究点目标入组 400 人开始时间: 2022年5月27日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 400
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 60 Years（—）
- 性别
- All
入选标准
- •People >18 years who were sexually traumatized in childhood
排除标准
- •Individuals with psychotic illnesses, with current substance abuse or with acute suicidality
研究者
相似试验
进行中（未招募）
不适用
A multi-national, multi-centre, randomized, double-blind, placebo-controlled, parallel-group study to assess the efficacy, tolerability and safety of 40 mg glatiramer acetate injection in subjects with amyotrophic lateral sclerosis (ALS) - n.a.Early stage of amyotrophic lateral sclerosis (ALS)MedDRA version: 8.1Level: PTClassification code 10002026EUCTR2006-001688-49-DETEVA Pharmaceutical Industries. Ltd.300
进行中（未招募）
不适用
A multi-national, multi-centre, randomized, double-blind, placebo-controlled, multiple-dose, parallel-group study to assess the efficacy, tolerability and safety of three doses of edratide (TV-4710) for injection administered subcutaneously to systemic lupus erythematosus (SLE) patients - PRELUDESystemic lupus erythematosus (SLE)MedDRA version: 7.1Level: PTClassification code 10042945EUCTR2005-001391-12-DETEVA Pharmaceutical Industries, Ltd.260
进行中（未招募）
1 期
A multi-national, multi-centre, randomized, double-blind, placebo-controlled, multiple-dose, parallel-group study to assess the efficacy, tolerability and safety of three doses of edratide (TV-4710) for injection administered subcutaneously to systemic lupus erythematosus (SLE) patients - PRELUDEEUCTR2005-001391-12-GBTEVA Pharmaceutical Industries, Ltd.260
进行中（未招募）
1 期
A multi-national, multi-centre, randomized, double-blind, placebo-controlled, parallel-group study to assess the efficacy, tolerability and safety of 40 mg glatiramer acetate injection in subjects with amyotrophic lateral sclerosis (ALS) - n.a.EUCTR2006-001688-49-GBTEVA Pharmaceutical Industries. Ltd.366
进行中（未招募）
1 期
A multi-national, multi-centre, randomized, double-blind, placebo-controlled, multiple-dose, parallel-group study to assess the efficacy, tolerability and safety of three doses of edratide (TV-4710) for injection administered subcutaneously to systemic lupus erythematosus (SLE) patients - PRELUDESystemic lupus erythematosus (SLE)MedDRA version: 7.1Level: PTClassification code 10042945EUCTR2005-001391-12-ESTEVA Pharmaceutical Industries, Ltd.260